Niagen Bioscience, Inc. Common Stock
NAGENiagen Bioscience, Inc. is a biotechnology company focused on developing and commercializing nicotinamide riboside (NR), a form of vitamin B3 that supports cellular health and energy metabolism. The company aims to leverage its proprietary NAD+ booster to address various age-related health conditions and promote overall wellness.
$6.99 +0.12 (1.74%)
Company News
National Advertising Division Finds Certain Reus Cata-Kor NAD+ Claims Supported; Recommends Others Be Modified or Discontinued
The National Advertising Division reviewed claims by Reus Research for its Cata-Kor NAD+ products, finding some claims supported while recommending modifications or discontinuation of others due to insufficient substantiation of health benefits and inadequate influencer disclosures.
